Wan Chai, Hong Kong, December 01, 2014 -- LEmed (Learning Edge Medical Ltd.), the specialist stem cell, laser therapy, research and distribution group, announced today that it will be offering stem cell & integrative treatment for Type 2 Diabetes.

Chairman Don Margolis said “Stem cell researchers continue to be amazed at the use of stem cell therapies to regenerate damage organs and tissues. Hereditary conditions, cancers, blood diseases and conditions such as diabetes mellitus are among the many conditions where stem cell research, development & treatmen shows positive and effective gains.”

Stem cell transplants and treatments for individuals diagnosed with type 1 & type 2 diabetes have shown positive results, including lowered blood sugar levels, and in some cases, complete reversal of the diabetic process.

Stem cell research facilities in Asia are leading the way in developing consistent treatments and technologies in stem cell therapy and stem cell transplantation to reduce and eradicate the disease process in growing numbers of individuals diagnosed with diabetes mellitus as well as those diagnosed with Type 1 diabetes, known as Juvenile Diabetes.

Backed by the support of the American Diabetes Association and other global diabetics organizations, researchers hoping for cures and better treatments for diabetes understand that this research offers the best hope for cure and treatment of diabetes, promoting insulin producing cells that will eradicate the need for injections and reduce symptoms of diabetes in the elderly.

LEmed have focused on developing cell replacement therapies that restore normal insulin function in those diagnosed with various forms of diabetes. Creating a dependable and unlimited supply of insulin producing cells through cell replacement therapies are currently undergoing clinical trials as well as procedures throughout the globe.

The focus of such technology development is to understand how to promote stem cells to transform into insulin producing beta cells. This process requires the activation of a variety of genes necessary for the development of insulin producing cells including Nuerogenin 3, Pdx1 and Pax4, Nkx6.1 and Isl-1 genes.

Understanding the basics of stem cell research and the staggering potential for potential cures of dozens of disease processes may help take some of the fear and confusion regarding such technology. The future of medical treatments for diabetes may very well lie in stem cell research, technology and stem cell transplantation, offering hope of cure, remission, and optimal health for millions around the world.

About Leading Edge Medical Ltd:
Cellular medicine is revolutionizing medical treatment in the 21st century and Leading Edge Medical's treatments are at the forefront of the field. Thousands of patients around the world have already benefited from bio-technologies using stem cells and intravenous laser therapy. Diseases once considered incurable are responding well to stem cell therapies and are restoring a quality of life to patients they thought they had lost forever.

LEmed is committed to applying modern day best practices to the growing field of regenerative medicine. At its advanced medical treatment facilities, LEmed offers personalized, ongoing care plans and the highest quality of customer service as part of its dedication to providing a better life for chronic disease patients.

Contact:
Jeffery Tobin
Leading Edge Medical, Ltd
14F, 8 Hennessy Road
China Hong Kong Tower
Wan Chai, Hong Kong, 999077
+852 2127 0684
[email protected]
http://www.healingmed.com